UnitedHealth Group Incorporated (UNH)
Latest news, insights and market data
Market Data
AI Insights
UnitedHealth announced a $5 billion stock buyback, indicating confidence in its future performance. Barclays also raised its price target to $441, reflecting positive sentiment among analysts. This buyback could enhance shareholder value, especially as the company navigates challenges in its commercial segment.
Latest News
| Title | Published |
|---|---|
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026 5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026 | about 5 hours ago |
JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating | about 6 hours ago |
Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating | about 6 hours ago |
A $5 Billion Reason to Buy UnitedHealth Stock Here A $5 Billion Reason to Buy UnitedHealth Stock Here | about 22 hours ago |
A $5 Billion Reason to Buy UnitedHealth Stock Here UnitedHealth’s $5 billion buyback announcement signals that the healthcare giant’s turnaround is gaining momentum, making it a lucrative opportunity. | about 22 hours ago |
2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027 Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older | about 22 hours ago |
Uncover the latest developments among dow jones stocks in today's session. Let's have a look at the top dow jones gainers and losers in the middle of the day of today's session. | about 23 hours ago |
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026
JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating
JPMorgan Adjusts Price Target on UnitedHealth Group to $516 From $466, Maintains Overweight Rating
Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating
Mizuho Adjusts Price Target on UnitedHealth Group to $493 From $470, Maintains Outperform Rating
A $5 Billion Reason to Buy UnitedHealth Stock Here
A $5 Billion Reason to Buy UnitedHealth Stock Here
A $5 Billion Reason to Buy UnitedHealth Stock Here
UnitedHealth’s $5 billion buyback announcement signals that the healthcare giant’s turnaround is gaining momentum, making it a lucrative opportunity.
2.6 Million People Lost Their Medicare Advantage Plan This Year: Here's How To Avoid Being Caught Off Guard For 2027
Losing a health plan is stressful at any age. Losing it in retirement, when a familiar doctor and a specific drug list are woven into daily life, is worse. Yet that is exactly what happened to a large group of older
Uncover the latest developments among dow jones stocks in today's session.
Let's have a look at the top dow jones gainers and losers in the middle of the day of today's session.